Case Report
Published on 25 Feb 2025
Ensartinib as a neoadjuvant therapy for stage IIIA non-small cell lung cancer patients with EML4-ALK fusion: a case report and literature review
in Thoracic Oncology
- 3,149 views
- 4 citations
Case Report
Published on 25 Feb 2025
in Thoracic Oncology
Case Report
Published on 25 Feb 2025
in Thoracic Oncology
Original Research
Published on 25 Feb 2025
in Thoracic Oncology
Original Research
Published on 24 Feb 2025
in Thoracic Oncology
Original Research
Published on 20 Feb 2025
in Thoracic Oncology
Original Research
Published on 20 Feb 2025
in Thoracic Oncology
Original Research
Published on 20 Feb 2025
in Thoracic Oncology
Original Research
Published on 18 Feb 2025
in Thoracic Oncology
Original Research
Published on 18 Feb 2025
in Thoracic Oncology
Case Report
Published on 18 Feb 2025
in Thoracic Oncology
Original Research
Published on 17 Feb 2025
in Thoracic Oncology
Case Report
Published on 17 Feb 2025
in Thoracic Oncology
Original Research
Published on 14 Feb 2025
in Thoracic Oncology
Case Report
Published on 14 Feb 2025
in Thoracic Oncology
Original Research
Published on 13 Feb 2025
in Thoracic Oncology
Correction
Published on 12 Feb 2025
in Thoracic Oncology
Correction
Published on 12 Feb 2025
in Thoracic Oncology
Case Report
Published on 10 Feb 2025
in Thoracic Oncology
Case Report
Published on 10 Feb 2025
in Thoracic Oncology
Brief Research Report
Published on 06 Feb 2025
in Thoracic Oncology
Case Report
Published on 06 Feb 2025
in Thoracic Oncology
Case Report
Published on 03 Feb 2025
in Thoracic Oncology
Original Research
Published on 31 Jan 2025
in Thoracic Oncology
Original Research
Published on 30 Jan 2025
in Thoracic Oncology